CTRI/2023/10/059019尚未招募Unknown
EVALUATION OF miRNA - 210 AS PROGNOSTIC BIOMARKER OF PRE-ECLAMPSIA - A CASE CONTRO
DR KOTA SAI MEGHANA0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1 Any pregnant woman with BP more than or equal to 140/90mmhg with two readings measured 6 hours apart with significant proteinuria (more than or equal to 300 mg of protein in a 24hr urine specimen or more than or equal to 1+ by dipstick) following 20 weeks of gestation in a previously normotensive woman
- •2Pregnant women age more than or equal to 18
- •3Singleton pregnancy
- •4Prenatal care at BLDE
排除标准
- •1 Any congenital fetal malformations or chromosomal abnormalities
- •2 Chronic Hypertension
- •3 Twins with pre eclampsia
- •4 Renal disease with pre eclampsia
- •5 Cardiac disease with pre eclampsia
- •6 Recent infection
- •7 APLA Syndrome
研究者
相似试验
招募中
不适用
microRNA as prognostic and diagnostic markers in malignant melanoma.C43.9Malignant melanoma of skin, unspecifiedDRKS00024417niversitätsklinikum Halle (Saale)10
Unknown
不适用
Diagnostic and Prognostic Value of MicroRNA in Breast Cancer PatientsBreast CancerNCT04778202Assiut University50
进行中（未招募）
不适用
Validation of miRNA biomarkers for the early diagnosis of lung cancerung cancerC34Malignant neoplasm of bronchus and lungDRKS00017455Hummingbird Diagnostics GmbH21
已完成
不适用
Validation of a miRNA biomarker signature for early detection of lung cancer.C34.1Upper lobe, bronchus or lungDRKS00031791Hummingbird Diagnostics359
进行中（未招募）
不适用
A study to evaluate the importance of biomarkers a type of blood compounds in determining the disease progression status in patient with Hodgkins lymphoma a type of blood cancer who will receive the standard treatmentCTRI/2017/11/010551Tata Memorial Hospital